Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. 31 January 2020. Rafael Carbunaru.

Executive Summary

Boston Scientific recently presented encouraging results of its COMBO study and discussed its partnership with IBM Health using digital health technologies and algorithms to gain an objective understanding of pain. See what Rafael Carbunaru, VP of R&D at Boston Scientific's neuromodulation division, said about it here.

"We believe that the typical measure of a 'sad face and happy face' doesn’t really describe pain. Our vision is to develop algorithms that will make our therapies smarter and autonomous to adapt with the patient’s needs." – Rafael Carbunaru, VP of R&D, Boston Scientific's neuromodulation division

Click here for a free trial of Medtech Insight

Related Content

Topics

UsernamePublicRestriction

Register

MT126187

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel